NCT01072604View on ClinicalTrials.gov

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Pharmacokinetics
Interventions
DRUG

Acetylsalicylic acid (Aspirin, BAY1019036)

One oral dose of new formula Aspirin Prototype 1 under fasting conditions

DRUG

Acetylsalicylic acid (Aspirin, BAY1019036)

One oral dose of new formula Aspirin Prototype 2 under fasting conditions

DRUG

Acetylsalicylic acid (Aspirin, BAYE4465)

One oral dose of Aspirin Plain Tablet under fasting conditions

DRUG

Acetylsalicylic acid (Aspirin, BAYE4465)

One oral dose of Aspirin Dry Granules under fasting conditions

Trial Locations (1)

07601

Hackensack

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01072604 - Pharmacokinetic Study Comparing Aspirin and Aspirin Granules | Biotech Hunter | Biotech Hunter